Keen to make a difference in people’s lives, PhD student Daniel Neumann decided to pursue a research career in prostate cancer after studying a Bachelor of Medical Science. Continue reading
In a promising new development, scientists working tirelessly at the Centre for Cancer Biology (CCB) have identified that high levels of a protein called ‘quaking’ contributes to the poor outlook for prostate cancer tumours that have become resistant to chemotherapy and other treatments. Continue reading
A clinical trial to test a new treatment for prostate cancer is currently underway at the Lyell McEwin Hospital, bringing hope to Australian men living with this disease. Continue reading
Cancer fighting T cells already present in our blood may hold the key to fighting tumours in prostate cancer, replacing the need for invasive surgery.
Research from the Basil Hetzel Institute for Translational Health Research (BHI), has found that activated T cells delivered to a localised area enhances their cancer killing potential. This is particularly effective when treating the early stages of prostate and breast cancers, which develop in a confined space. Continue reading
Approximately 1 in 7 Australian men will be diagnosed with prostate cancer by the age of 75-years-old. Thankfully, innovative research is underway to improve outcomes and save the lives of the men in your life. Continue reading
While there are many treatments available for prostate cancer, once the disease spreads, it becomes more difficult to treat. Professor Greg Goodall and his team at the Centre for Cancer Biology are leading vital research to stop the growth and spread of this devastating disease. They are focused on one crucial molecule which plays an important role in our body – the RNA molecule. Continue reading
Dedicated researcher Dr Irene Zinonos is continuing her groundbreaking research at the Basil Hetzel Institute for Translational Health Research (BHI), working alongside Associate Professor Lisa Butler, to develop a completely new way to predict tumour behaviour and help people make more effective treatment choices. Continue reading
“I feel very strongly about advocating for men’s health and prostate cancer is the most common cancer in men.” Continue reading
An exciting study is underway that could potentially lead to new treatments for metastatic prostate cancer, cancer that has spread to other areas of the body, at the world-class Centre for Cancer Biology in Adelaide.
An exciting project set to explore a newly discovered pathway that could lead to new treatments for metastatic prostate cancer is now underway at the Centre for Cancer Biology (CCB). Supported by Australian Prostate Cancer (APC), with partner The Hospital Research Foundation (THRF), this incredible, innovative research is set to save lives. Continue reading